About Synthetic Biology
The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems that provide improved and desirable functions. It is considered to be a form of extreme genetic engineering because it not only alters existing metabolic pathways, but also creates new ones. The engineered biological systems can be used to manipulate chemicals, fabricate materials and structures, produce energy, provide GM food, improve the efficiency of drugs and vaccines, and maintain a sustainable environment.
TechNavio's analysts forecast the Global Synthetic Biology market will grow at a CAGR of 33.8 percent over the period 2013-2018.
Covered in this Report
The Global Synthetic Biology market can be categorized on the basis of technology into four segments: Genome Engineering. DNA Sequencing, Bioinformatics, and Biological Components and Integrated Systems.
TechNavio's report, the Global Synthetic Biology Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Synthetic Biology market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• Amyris Inc.
• E. I. du Pont de Nemours and Co.
• Thermo Fisher Scientific Inc.
• Synthetic Genomics Inc.
Other Prominent Vendors
• Algenol Biofuels Inc.
• ATG:biosynthetics GmbH
• Bayer AG
• Bioneer Corp.
• Biosearch Technologies Inc.
• Bristol-Myers Squibb Co.
• CBC Comprehensive Biomarker Center GmbH
• Cobalt Technologies
• Evolva Holdings SA
• Exxon Mobil Corp.
• GeneWorks Pty Ltd.
• Genomatica Inc.
• Gevo Inc.
• Ginkgo Bioworks
• Green Biologics Ltd.
• New England Biolabs Inc.
• OriGene Technologies Inc.
• REG Life Sciences LLC
• Royal DSM
• Synthorx Inc.
Key Market Driver
• Increased R&D in Synthetic Biology
• For a full, detailed list, view our report.
Key Market Challenge
• Lack of Modularized Biological Parts
• For a full, detailed list, view our report.
Key Market Trend
• Growing Demand for GM Crops
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product and Service Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Technology
08. Market Segmentation by Product
09. Market Segmentation by Applications
10. Geographical Segmentation
10.1 Synthetic Biology Market in the Americas
10.1.1 Market Size and Forecast
10.2 Synthetic Biology Market in the EMEA Region
10.2.1 Market Size and Forecast
10.3 Synthetic Biology Market in the APAC Region
10.3.1 Market Size and Forecast
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Vendor Share Analysis 2013
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Amyris Inc.
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Business Strategy
19.1.4 Geographical Segmentation
19.1.5 Key Developments
19.1.6 SWOT Analysis
19.1.7 Strengths
19.1.8 Weakness
19.1.9 Opportunities
19.1.10 Threats
19.2 E. I. du Pont de Nemours and Company
19.2.1 Key Facts
19.2.2 Business Description
19.2.3 Business Segmentation
19.2.4 Business Strategy
19.2.5 Revenue Segmentation
19.2.6 Revenue Comparison 2013-2011
19.2.7 Geographical Segmentation
19.2.8 Key Developments
19.2.9 SWOT Analysis
19.2.10 Strengths
19.2.11 Weakness
19.2.12 Opportunities
19.2.13 Threats
19.3 Synthetic Genomics, Inc.
19.3.1 Key Facts
19.3.2 Business Overview/ Description
19.3.3 Business Strategy
19.3.4 Key Information
19.3.5 SWOT Analysis
19.3.6 Strengths
19.3.7 Weakness
19.3.8 Opportunities
19.3.9 Threats
19.4 Thermo Fisher Scientific Inc.
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation
19.4.4 Revenue Segmentation by Business
19.4.5 Revenue Segmentation by Products
19.4.6 Sales by Geographical Segmentation
19.4.7 Business Strategy
19.4.8 Key Information
19.4.9 SWOT Analysis
19.4.10 Strengths
19.4.11 Weaknesses
19.4.12 Opportunities
19.4.13 Threats
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Synthetic Biology Market 2013-2018 (US$ million)
Exhibit 3: Global Synthetic Biology Market Segmentation by Technology
Exhibit 4: Global Synthetic Biology Market Segmentation by Technology 2013
Exhibit 5: Global Synthetic Biology Market Segmentation by Product
Exhibit 6: Global Synthetic Biology Market Segmentation by Applications
Exhibit 7: Global Synthetic Biology Market Segmentation by Applications 2013
Exhibit 8: Global Synthetic Biology Market by Geographical Segmentation 2013
Exhibit 9: Synthetic Biology Market in the Americas 2013-2018 (US$ million)
Exhibit 10: Synthetic Biology Market in the EMEA Region 2013-2018 (US$ million)
Exhibit 11: Synthetic Biology Market in the APAC Region 2013-2018 (US$ million)
Exhibit 12: Number of Entities Conducting Research in the Global Synthetic Biology Market 2013
Exhibit 13: Amyris Inc.: Segmentation by Geography 2013
Exhibit 14: Amyris Inc.: Revenue Comparison by Geographical Segmentation 2013-2011 (US$ million)
Exhibit 15: Business Segmentation of DuPont: 2013
Exhibit 16: Revenue Segmentation of DuPont 2013
Exhibit 17: DuPont:Revenue Comparison by business segments for 2013-2011(US$ million)
Exhibit 18: DuPont by Geographical Segmentation 2013
Exhibit 19: DuPont Revenue Comparison by Geography segments for 2013-2011 (US$ million)
Exhibit 20: Business Segmentation of Thermo Fisher Scientific Inc.
Exhibit 21: Revenue by Business Segments of Thermo Fisher Scientific Inc. 2013
Exhibit 22: Revenue by Products of Thermo Fisher Scientific Inc. 2013
Exhibit 23: Sales by Geographical Segmentation of Thermo Fisher Scientific Inc. 2013
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
